RadNet (RDNT) 2026 Jefferies Healthcare Services and Technology Conference summary
Event summary combining transcript, slides, and related documents.
2026 Jefferies Healthcare Services and Technology Conference summary
15 Sep, 2026Business evolution and growth
Imaging center business generates over $2 billion in revenue, while digital health is guided to $135–$145 million, with the latter growing at 90% in Q2.
Core imaging services reported 25% revenue growth last quarter, with 10%+ same-store MRI growth and 8–9% same-store PET/CT growth.
Digital health tools have enabled increased productivity, allowing more efficient scheduling and faster reporting, directly supporting same-store growth.
Demand for imaging remains strong, driven by new technology, demographic trends, and a shift to lower-cost outpatient settings.
Margin expansion opportunities exist through geographic diversification and increasing advanced procedure mix.
Digital health and AI strategy
Digital health segment is split between clinical AI (image analysis) and operational IT (workflow, scheduling, reporting), each contributing about half of segment revenue.
Revenue is roughly 35% internal and 65% external, with over 3,000 external customers and a SaaS land-and-expand model.
Clinical AI products include 27–28 FDA-cleared tools, with new products like breast arterial calcification and risk assessment pending clearance.
Monetization includes CPT codes, self-pay models, and productivity gains; mammography self-pay revenue is approaching $20 million annually.
Operational AI tools improve efficiency, such as remote scanning (TechLive) and advanced reporting, and are increasingly adopted by external clients.
Competitive positioning and partnerships
Unified operating system approach differentiates the offering, allowing clients to adopt modular solutions and expand over time.
Hospital partnerships are increasing, with 36% of imaging centers in JV partnerships, aiming for 50%.
Digital health solutions are being tailored for both outpatient and inpatient settings, expanding the addressable market.
The company competes with established PACS vendors by offering a broader, integrated suite rather than just a viewer.
Flexibility in product adoption allows clients to integrate individual tools alongside existing systems.
Latest events from RadNet
- AI-driven innovation, operational scale, and health system partnerships fuel growth and efficiency.RDNT
Morgan Stanley 24th Annual Global Healthcare Conference - Record revenue and EBITDA, strong Digital Health growth, and raised guidance mark robust results.RDNT
Q2 2026 - Advanced imaging, AI, and acquisitions drive robust growth and margin expansion for 2026.RDNT
47th Annual Raymond James Institutional Investor Conference - AI-powered imaging and outpatient expansion drive double-digit growth and industry leadership.RDNT
44th Annual J.P. Morgan Healthcare Conference - Record revenue and EBITDA growth, AI expansion, and acquisitions led to raised 2025 guidance.RDNT
Q3 2025 - Advanced imaging and digital health drive robust growth, with major AI and OEM partnerships announced.RDNT
Bank of America Securities 2024 Leveraged Finance Conference - Record Q2 revenue and EBITDA, strong AI growth, and raised 2024 guidance amid cost pressures.RDNT
Q2 2024 - $103M all-stock deal forms a global AI breast imaging leader, targeting $7M+ cost synergies.RDNT
M&A Announcement - Q1 revenue up 9.2%, guidance raised, and iCAD acquisition to expand AI breast health.RDNT
Q1 2025